Cargando…
Choosing a cellular model to study SARS-CoV-2
As new pathogens emerge, new challenges must be faced. This is no different in infectious disease research, where identifying the best tools available in laboratories to conduct an investigation can, at least initially, be particularly complicated. However, in the context of an emerging virus, such...
Autores principales: | Pires De Souza, Gabriel Augusto, Le Bideau, Marion, Boschi, Céline, Wurtz, Nathalie, Colson, Philippe, Aherfi, Sarah, Devaux, Christian, La Scola, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634005/ https://www.ncbi.nlm.nih.gov/pubmed/36339347 http://dx.doi.org/10.3389/fcimb.2022.1003608 |
Ejemplares similares
-
Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells
por: Pires de Souza, Gabriel Augusto, et al.
Publicado: (2021) -
Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells
por: de Souza, Gabriel Augusto Pires, et al.
Publicado: (2021) -
Limited permissibility of ENL-R and Mv-1-Lu mink cell lines to SARS-CoV-2
por: Le Bideau, Marion, et al.
Publicado: (2022) -
Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19
por: Osman, Ikram Omar, et al.
Publicado: (2022) -
Giant Viruses of Amoebas: An Update
por: Aherfi, Sarah, et al.
Publicado: (2016)